Screener — stockrow

Reset Show charts

Annual Dividend Yield

Your own ranges are part of Powerpack. Powerpack

Annual Dividend Rate

Your own ranges are part of Powerpack. Powerpack

Payout Ratio

Your own ranges are part of Powerpack. Powerpack

Dividend Safety Score

Your own ranges are part of Powerpack. Powerpack

Dividend Champion (3y)

Dividend Champion (5y)

Dividend Champion (10y)

Dividend Aristocrat

Dividends Paid (Common)

Your own ranges are part of Powerpack. Powerpack

Issuance/Purchase of Shares

Your own ranges are part of Powerpack. Powerpack

Free Cash Flow Yield

Your own ranges are part of Powerpack. Powerpack

Matching companies: 5

1 filter active

Table Snapshots

High Tide Inc.

HITI Healthcare · Pharmaceutical Retailers · CA

$2.64 −8.97% 1Y

Low $2.02 High $3.07

High Tide operates across Canada, the United States, and Europe, with a diversified portfolio of businesses that include retail cannabis stores, e-commerce platforms, and wholesale distribution. The company is publicly traded on the TSX Venture Exchange under the ticker symbol “HITI” and is also listed on the NASDAQ, reflecting its commitment to transparency and growth in the global market.

Market cap $234.4M

Revenue growth (Q) +30.7%

EPS growth (Q) +800.0%

FCF growth (Q) −7.91%

Revenue growth (next yr) +27.6%

Net margin −4.59%

ROE −25.1%

P/E —

Forward P/E 23.4×

P/FCF 20.8×

Dividend yield —

Insider ownership 11.7%

Insider buys / sells (12M) — —

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$277.2M	$361.6M	$383.7M	$424.0M	$519.7M
EPS	−$0.89	−$0.39	−$0.04	−$0.44	−$0.32
Free cash flow	−$3.5M	$10.8M	$19.6M	$9.7M	$11.1M
Net debt	$28.7M	$25.9M	$2.8M	$36.1M	$45.7M

PetMed Express, Inc.

PETS Healthcare · Pharmaceutical Retailers · US

$1.21 −50.6% 1Y

Low $1.15 High $4.10

PetMed Express, Inc. (PETS), founded in 1996, is a leading pet pharmacy in the United States. Headquartered in Delray Beach, Florida, the company specializes in providing prescription and non-prescription pet medications, health products, and supplies directly to consumers.

Market cap $26.9M

Revenue growth (Q) −19.9%

EPS growth (Q) +83.0%

FCF growth (Q) +38.6%

Revenue growth (next yr) −16.7%

Net margin −17.3%

ROE −78.6%

P/E —

Forward P/E −2.4×

P/FCF —

Dividend yield —

Insider ownership 33.6%

Insider buys / sells (12M) <$0.1M —

Reported	FY2023	FY2024	FY2025	FY2026	TTM
Revenue	$247.6M	$274.1M	$227.0M	$179.0M	$168.9M
EPS	$0.25	−$0.37	−$0.30	−$2.74	−$1.38
Free cash flow	$22.5M	−$194.0K	−$395.0K	−$33.0M	−$27.8M
Net debt	−$104.1M	−$55.3M	−$54.7M	−$21.4M	−$13.1M

Pomdoctor Limited - Sponsored ADR

POM Healthcare · Pharmaceutical Retailers · CN

$1.82 −98.3% 1Y

Low $0.43 High $103.50

Market cap $11.6M

Revenue growth (Q) —

EPS growth (Q) —

FCF growth (Q) —

Revenue growth (next yr) —

Net margin —

ROE —

P/E —

Forward P/E —

P/FCF —

Dividend yield —

Insider ownership —

Insider buys / sells (12M) — —

Reported	FY2024	FY2025	TTM
Revenue	$46.9M	$57.2M	—
EPS	−$8.12	−$31.23	—
Free cash flow	−$2.2M	−$21.4M	—
Net debt	$59.0M	$63.3M	$64.1M

Scienture Holdings, Inc.

SCNX Healthcare · Pharmaceutical Retailers · US

$3.14 −83.2% 1Y

Low $2.64 High $19.47

Scienture Holdings, Inc. (SCNX) is a diversified global company specializing in innovative solutions across multiple industries. Founded in 2005, SCNX has grown from a small startup into a multinational corporation with a strong presence in technology, healthcare, and sustainable energy sectors.

Market cap $5.1M

Revenue growth (Q) +3,235.9%

EPS growth (Q) +85.4%

FCF growth (Q) −54.0%

Revenue growth (next yr) +743.4%

Net margin −4,621.0%

ROE −53.5%

P/E —

Forward P/E −0.7×

P/FCF —

Dividend yield 0.00%

Insider ownership 19.2%

Insider buys / sells (12M) — —

Reported	FY2022	FY2023	FY2024	FY2025	TTM
Revenue	$10.3M	$1.4M	$136.6K	$431.6K	$821.3K
EPS	−$153.67	−$187.25	$62.00	−$67.50	−$52.50
Free cash flow	−$1.6M	−$2.2M	−$14.3M	−$13.4M	−$14.4M
Net debt	−$398.1K	$24.7K	$719.2K	−$6.7M	$1.4M

Ridgetech Inc.

RDGT Healthcare · Pharmaceutical Retailers · CN

$1.00 −99.7% 1Y

Low $0.67 High $760.12

Market cap $2.7M

Revenue growth (Q) +113.1%

EPS growth (Q) 0.00%

FCF growth (Q) +4,848.3%

Revenue growth (next yr) +13.4%

Net margin −7.77%

ROE 0.00%

P/E —

Forward P/E −5.6×

P/FCF 0.0×

Dividend yield —

Insider ownership 0.00%

Insider buys / sells (12M) $0.2M $0.1M

Reported	FY2023	FY2024	FY2025	FY2026
Revenue	$148.8M	$124.0M	$120.0M	$132.2M
EPS	−$2.07	−$437.31	$274.63	−$17.21
Free cash flow	−$3.3M	−$4.1M	$632.5K	−$1.4M
Net debt	−$31.6M	−$4.3M	−$18.5M	−$17.9M

Stockrow Weekly